S
Steve Su
Researcher at The George Institute for Global Health
Publications - 17
Citations - 6242
Steve Su is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Knee pain & Back pain. The author has an hindex of 12, co-authored 17 publications receiving 5802 citations. Previous affiliations of Steve Su include Queensland University of Technology & University of Western Australia.
Papers
More filters
Journal ArticleDOI
Intensive versus conventional glucose control in critically ill patients.
Nice-Sugar Study Investigators,Dean R. Chittock,Steve Su,D. Blair,Denise Foster,Rinaldo Bellomo,Deborah J. Cook,Vinay Dhingra,Peter Dodek,Paul C. Hébert,William R. Henderson,Stephane Heritier,Daren K. Heyland,Colin McArthur,Ellen McDonald,Imogen Mitchell,Robyn Norton,J. Potter,Bruce G. Robinson,Juan J. Ronco +19 more
TL;DR: In this large, international, randomized trial, it was found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted in lower mortality than did a target of 81 to 108 mg perDeciliter.
Journal ArticleDOI
Intensity of continuous renal-replacement therapy in critically ill patients.
Rinaldo Bellomo,Alan Cass,Louise Cole,Simon Finfer,Martin Gallagher,Serigne Lo,Colin McArthur,Shay McGuinness,John Myburgh,Robyn Norton,Carlos Scheinkestel,Steve Su +11 more
TL;DR: In critically ill patients with acute kidney injury, treatment with higher-intensity continuous renal-replacement therapy did not reduce mortality at 90 days.
Journal ArticleDOI
An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial.
Rinaldo Bellomo,Alan Cass,Louise Cole,Simon Finfer,Martin Gallagher,Joanne Lee,Serigne Lo,Colin McArthur,Shay McGuiness,Robyn Norton,John Myburgh,Carlos Scheinkestel,Steve Su +12 more
TL;DR: In the RENAL study, a negative mean daily fluid balance was consistently associated with improved clinical outcomes and may be a target for specific manipulation in future interventional trials of critically ill patients receiving renal replacement therapy.
Journal ArticleDOI
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
Marlene Fransen,Maria Agaliotis,L. Nairn,M. Votrubec,Lisa Bridgett,Steve Su,Stephen Jan,Lyn March,John Edmonds,Robyn Norton,Mark Woodward,Richard O. Day +11 more
TL;DR: Allocation to the glucosamine–chondroitin combination resulted in a statistically significant reduction in JSN at 2 years, and none of the treatment allocation groups demonstrated significant symptomatic benefit above placebo.
Journal ArticleDOI
Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study
Yufang Bi,Runlin Gao,Anushka Patel,Steve Su,Wei Gao,Dayi Hu,Dejia Huang,Lingzhi Kong,Wenhang Qi,Yangfeng Wu,Yuejin Yang,Fiona Turnbull +11 more
TL;DR: Opportunities to improve the use and maintenance of appropriate combinations of evidence-based treatment among patients with acute coronary syndromes presenting to hospitals in China are highlighted.